Detail-oriented Laboratory Manager highly effective at keeping laboratories running smoothly and efficiently. Knowledgeable about managing supplies, equipment and facilities. Pursuing new professional challenges with the opportunity to make a positive impact on laboratory operations and research success.
Poster Presentations:
• Bailey, A.W., Suri, A., Suzuki, M., Gross, J., Evans, S., Piper, D.R., Topczewski, J., Tomita, T., Sredni, S.T. A Functional Screening of the kinome identifies the Polo-like kinase 4 as a Potential Therapeutic Target for Malignant Rhabdoid Tumors, and Possibly, Other Embryonal Tumors of the Brain. In: Annual Research Scholar Day (2017) at Ann and Robert H. Lurie Children’s Hospital of Chicago.
• Bailey, A.W., Suri, A., Suzuki, M., Hashizume, R., Tomita, T., Sredni, S.T. Inhibiting PLK4: A New Therapeutic Option for Embryonal Brain Tumors. In: Annual Research Scholar Day (2018) at Ann and Robert H. Lurie Children’s Hospital of Chicago. And the 14th Annual Lewis Landsberg Research Day (2018) at Northwestern University’s Robert H. Lurie Cancer Center
• Bailey, A.W., Suri, A., Tavares, M.T., Roy, S.M., Gunoseoyo, H., Kozikowski, A.P., Tomita, T., Sredni, S.T. Pre-clinical Evaluation of Protein Kinase Inhibitors with PLK4 Cross-over Potential. In: Annual Research Scholar Day (2019) at Ann and Robert H. Lurie Children’s Hospital of Chicago. And the 15th Annual Lewis Landsberg Research Day (2019) at Northwestern University’s Robert H. Lurie Cancer Center
• Bailey, A.W., Suri, A., Roy, S.M., Watterson, D.M., Tomita, T., Sredni, S.T. Inhibition of the p38a MAPK pathway sensitizes malignant solid tumors, from both children and adults, to approved therapies: A proof-of-concept in vitro study. In: Annual Research Scholar Day (2020) at Ann and Robert H. Lurie Children’s Hospital of Chicago- Zoom poster session
• Suri, A., Watanabe, J., Ishi, Y., Abe, K., Hashizume, R. Development of Novel Histone Demethylase Inhibitor against DIPG. In: Annual Research Scholar Day (2022) at Ann and Robert H. Lurie Children’s Hospital of Chicago.
• Suri, A., Montagano, L., Husain, S. A Landscape Assessment of Mental health Resources Available to Youth in the Austin Community of Chicago. In: DePaul Graduate Forum (2022) at Ann and Robert H. Lurie Children’s Hospital of Chicago.
Peer Reviewed Publications:
• Eksi, S., Suri, A., & Williamson, K. C. (2008). Sex- and stage-specific reporter gene expression in Plasmodium falciparum. Molecular and biochemical parasitology, 160(2), 148–151. https://doi.org/10.1016/j.molbiopara.2008.04.005 PMID:18490066
• Eksi, S., Morahan, B. J., Haile, Y., Furuya, T., Jiang, H., Ali, O., Xu, H., Kiattibutr, K., Suri, A., Czesny, B., Adeyemo, A., Myers, T. G., Sattabongkot, J., Su, X. Z., & Williamson, K. C. (2012). Plasmodium falciparum gametocyte development 1 (Pfgdv1) and gametocytogenesis early gene identification and commitment to sexual development. PLoS pathogens, 8(10), e1002964. https://doi.org/10.1371/journal.ppat.1002964. PMID:23093935
• Tanaka, T. Q., Deu, E., Molina-Cruz, A., Ashburne, M. J., Ali, O., Suri, A., Kortagere, S., Bogyo, M., & Williamson, K. C. (2013). Plasmodium dipeptidyl aminopeptidases as malaria transmission-blocking drug targets. Antimicrobial agents and chemotherapy, 57(10), 4645–4652. https://doi.org/10.1128/AAC.02495-12. PMID:23836185
• Sredni, S. T., Bailey, A. W., Suri, A., Hashizume, R., He, X., Louis, N., Gokirmak, T., Piper, D. R., Watterson, D. M., & Tomita, T. (2017). Inhibition of polo-like kinase 4 (PLK4): a new therapeutic option for rhabdoid tumors and pediatric medulloblastoma. Oncotarget, 8(67), 111190–111212. https://doi.org/10.18632/oncotarget.22704. PMID:29340047
• Bailey, A. W., Suri, A., Chou, P. M., Pundy, T., Gadd, S., Raimondi, S. L., Tomita, T., & Sredni, S. T. (2018). Polo-Like Kinase 4 (PLK4) Is Overexpressed in Central Nervous System Neuroblastoma (CNS-NB). Bioengineering, 5(4), 96. https://doi.org/10.3390/bioengineering5040096. PMID:30400339
• Suri, A., Bailey, A. W., Tavares, M. T., Gunosewoyo, H., Dyer, C. P., Grupenmacher, A. T., Piper, D. R., Horton, R. A., Tomita, T., Kozikowski, A. P., Roy, S. M., & Sredni, S. T. (2019). Evaluation of Protein Kinase Inhibitors with PLK4 Cross-Over Potential in a Pre-Clinical Model of Cancer. International journal of molecular sciences, 20(9), 2112. https://doi.org/10.3390/ijms20092112. PMID:31035676
• Alsayed, S., Suri, A., Bailey, A. W., Lane, S., Werry, E. L., Huang, C. C., Yu, L. F., Kassiou, M., Sredni, S. T., & Gunosewoyo, H. (2021). Synthesis and antitumour evaluation of indole-2-carboxamides against paediatric brain cancer cells. RSC medicinal chemistry, 12(11), 1910–1925. https://doi.org/10.1039/d1md00065a
• Ishi, Y., Zhang, Y., Zhang, A., Sasaki, T., Piunti, A., Suri, A., Watanabe, J., Abe, K., He, X., Katagi, H., Bhalla, P., Natsumeda, M., Zou, L., Shilatifard, A., & Hashizume, R. (2022). Therapeutic Targeting of EZH2 and BET BRD4 in Pediatric Rhabdoid Tumor. Molecular cancer therapeutics, molcanther.MCT-21-0646-A.2021. Advance online publication. https://doi.org/10.1158/1535-7163.MCT-21-0646